Arimoclomol Terminated Phase 3 Trials for Amyotrophic Lateral Sclerosis (ALS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03836716Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial